Search Results - "Saketkoo, L"

Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability by Hendriks, C. M. R., Saketkoo, L. A., Elfferich, M. D. P., De Vries, J., Wijnen, P. A. H. M., Drent, M.

“…Objective Sarcoidosis, an inflammatory multi-organ disease with a wide variety of clinical manifestations, affecting people of working age. Patients suffer…”
Get full text

There is a need for new systemic sclerosis subset criteria. A content analytic approach by Johnson, SR, Soowamber, ML, Fransen, J, Khanna, D, Van Den Hoogen, F, Baron, M, Matucci-Cerinic, M, Denton, CP, Medsger, TA, Carreira, PE, Riemekasten, G, Distler, J, Gabrielli, A, Steen, V, Chung, L, Silver, R, Varga, J, Müller-Ladner, U, Vonk, MC, Walker, UA, Wollheim, FA, Herrick, A, Furst, DE, Czirjak, L, Kowal-Bielecka, O, Del Galdo, F, Cutolo, M, Hunzelmann, N, Murray, CD, Foeldvari, I, Mouthon, L, Damjanov, N, Kahaleh, B, Frech, T, Assassi, S, Saketkoo, LA, Pope, JE

“…Objectives. Systemic sclerosis (SSc) is heterogenous. The objectives of this study were to evaluate the purpose, strengths and limitations of existing SSc…”
Get full text

C106 MONEY DON'T MATTER TONIGHT: PULMONARY HYPERTENSION ASSESSMENT, PROGNOSTICATION, AND TREATMENT: Changes In Hemodynamic Classification Over Time In Systemic Sclerosis-Associated Pulmonary Hypertension: Observations From The Pharos Cohort by Lammi, M R, Saketkoo, L, Gordon, J, Steen, V

“…PHAROS Investigators Corresponding author's email: mlammi@lsuhsc.edu Introduction: Systemic sclerosis-associated pulmonary hypertension (SSc-PH) may be…”
Get full text

C58 CLINICAL PULMONARY VASCULAR DISEASE: The Prevalence Of Sexual Dysfunction In Women With Pulmonary Hypertension by Tartavoulle, T, Aubin, A, Lammi, M R, Saketkoo, L

Get full text

Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment by Bruni, Cosimo, Heidenreich, Sebastian, Duenas, Ashley, Hoffmann-Vold, Anna-Maria, Gabrielli, Armando, Allanore, Yannick, Chatelus, Emmanuel, Distler, Jörg H W, Hachulla, Eric, Hsu, Vivien M, Hunzelmann, Nicolas, Khanna, Dinesh, Truchetet, Marie-Elise, Walker, Ulrich A, Alves, Margarida, Schoof, Nils, Saketkoo, Lesley Ann, Distler, Oliver

“…Abstract Objectives Treatments for SSc-associated interstitial lung disease (SSc-ILD) differ in attributes, i.e. mode of administration, adverse events (AEs)…”
Get full text

B108 DIAGNOSTIC AND PROGNOSTIC ASSESSMENT OF PULMONARY VASCULAR DISEASE: Predictors Of Death And Hospitalization In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: Analysis Of The Pulmonary Hypertension Assessment And Recognition Of Outcomes In Scleroderma (pharos) Registry by Lammi, M R, Chung, L, Saketkoo, L, Steen, V

Get full text

A102 HIGHLIGHTS IN PATIENT-CENTERED RESEARCH: METHODS AND OUTCOMES: Perceptions Of A Modified Mindfulness Training (mt) Program In Sarcoidosis by Saketkoo, L, Young, J, Adell, R, Karpinski, A C, Walker, M, Russell, A-M

Get full text

D54 CLINICAL PULMONARY HYPERTENSION: Red Cell Distibution Width As A Biomarker Of Pulmonary Hypertension by Petrauskas, L, Saketkoo, L A, Saito, S, Jaligam, V, DeBoisblanc, B, Lammi, M R

Get full text

C101 SARCOIDOSIS: A Novel Method To Quantitate Fluorodeoxyglucose By Positron Emission Tomography (pet) In The Lung Parenchyma Of Sarcoidosis Patients by Keijsers, R, Sweiss, N, Saketkoo, L A, Lower, E, Baughman, R P

Get full text

Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training by Snow, Marcus H, Saketkoo, Lesley-Ann, Frech, Tracy M, Stever, Jacob R, Lebedoff, Nicholas, Herrick, Ariane L, Cutolo, Maurizio, Smith, Vanessa

Get full text

B104 TICKET TO RIDE: MOVING FORWARD WITH SARCOIDOSIS EVALUATION AND TREATMENT: Assessment Of Protective Factors Of Bone Mineral Density In A New Orleans Sarcoidosis Population by Walker, M, Janot, A C, Yu, M, Grewal, H K, Lammi, M R, Saketkoo, L

Get full text

C102 STATEGIES TO UNDERSTAND ILD: REGISTRIES, PROGNOSTIC INDICATORS AND MORE: Trajectory Of Symptom Burden, Impact And Survival In An Idiopathic Pulmonary Fibrosis Population by Russell, A-M, Scholand, M, Snyder, E A, Doyle, A-M, Russell, A, Burdett, C, Lasky, J, Saketkoo, L A

Get full text

C53 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION II: Does Mycophenolate Mofetil (mmf) Have An Effect On Pulmonary Hemodynamics? Observations From The Pulmonary Hypertension Assessment And Recognition Of Outcomes In Scleroderma (pharos) Cohort by Saketkoo, L, Lammi, M R, Gordon, J, Lauto, P, Steen, V

Get full text

C53 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION II: Characteristics Of Systemic Sclerosis Patients With Pulmonary Hypertension And A Pulmonary Capillary Wedge Pressure >15 In The Pharos (pulmonary Hypertension Assessment And Recognition Of Outcomes In Scleroderma) Registry by Lammi, M R, Saketkoo, L, Gordon, J, Lauto, P, Steen, V

Get full text

C58 CLINICAL PULMONARY VASCULAR DISEASE: Experience Of Multi-Dimensional Fatigue In Pulmonary Hypertension: Fatigue Is Severe Regardless Of Dyspnea Severity by Tartavoulle, T M, Aubin, A, Lammi, M R, Lauto, P, Saito, S, DeBoisblanc, B, Distler, O, Saketkoo, L

Get full text

C102 STATEGIES TO UNDERSTAND ILD: REGISTRIES, PROGNOSTIC INDICATORS AND MORE: Impact, Survival, Symptoms And Management: Us And Uk Patient Perceptions Of Living With Idiopathic Pulmonary Fibrosis by Russell, A-M, Scholand, M, Snyder, E A, Russell, A, Burdett, C, Doyle, A-M, Lasky, J, Renzoni, E, Wells, A, Saketkoo, L

Get full text

D54 CLINICAL PULMONARY HYPERTENSION: Endothelial Microparticles As Biomarkers Of Pulmonary Hypertension In Systemic Sclerosis by Lammi, M R, Saketkoo, L A, Okpechi, S, Wyczechowska, D, Bauer, N, Pyakurel, K, Ghonim, M, Saito, S, Jaligam, V, DeBoisblanc, B, Boulares, A H

Get full text

International Classification of Functioning, Disability and Health Core Set construction in systemic sclerosis and other rheumatic diseases: a EUSTAR initiative by SAKETKOO, Lesley Ann, ESCORPIZO, Reuben, KEEN, Kevin J, FLIGELSTONE, Kim, DISTLER, Oliver

“…To outline rationale and potential strategies for rheumatology experts to be able to develop disease-specific Core Sets under the framework of the…”
Get full text

C25 THUNDERBALL: SPEEDING FORWARD OUR UNDERSTANDING OF SARCOIDOSIS: Cigarette Smoking And Male Sex Are Independent Risk Factors For Ocular Sarcoidosis by Janot, A C, Huscher, D, Walker, M, Grewal, H K, Cenac, S L, Yu, M, Lammi, M R, Saketkoo, L

Get full text

B22 THAT'LL BE THE DAY: UNDERSTANDING IPF RISK FACTORS AND OUTCOMES: The World Health Organization (who) International Classification Of Functioning, Disability, And Health (icf) Core Sets For Connective Tissue Disease Interstitial Lung Disease (ctd-Ild) And Idiopathic Pulmonary Fibrosis (ipf) - A Necessary Map To Health Care Provision In The Era Of Icd-11 by Saketkoo, L, Escorpizo, R, Keen, K J, Fligelstone, K, Lammi, M R, LeSage, D, Russell, A-M, Birring, S S, Sarver, C, Varga, J, Distler, O

Get full text